Literature DB >> 20638687

Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.

Chien-Ying Wang1, Mu-Shun Huang, Min-Hsiung Huang, Hui-Chen Lee, Han-Shui Hsu.   

Abstract

BACKGROUND: The aim of this study is to evaluate the prognostic significance of preoperative and postoperative serum carcinoembryonic antigen (CEA) levels in patients with stage I non-small-cell lung cancer.
MATERIAL AND METHODS: A retrospective review of the medical records of 257 patients with stage I lung cancer undergoing surgical resection was performed. The clinical data of each patient was collected for analysis including age, smoking habits, gender, preoperative and postoperative serum CEA levels, tumor diameter, histologic type, visceral pleural invasion, pathologic stage, and type of operation.
RESULTS: Adenocarcinoma was more often associated with elevated preoperative CEA level compared with non-adenocarcinoma. Tumor histology, however, did not influence postoperative CEA levels. In the univariate analysis, age, serum CEA level, and pathologic stage were prognostic factors. Patients with normal preoperative serum CEA levels had better 5-y survival than patients with high preoperative serum CEA levels (71.1% versus 54.6%, P = 0.016). The patients with a persistently high serum CEA level after surgery had worst prognosis. Multivariate analysis demonstrated that older age (≥65) and persistently high serum CEA levels were independent significant prognostic factors in patients with stage I lung cancer.
CONCLUSIONS: Age (≥65 years) and preoperative and postoperative serum CEA levels are independent prognostic factors in patients with stage I lung cancer. Patients with a persistently high serum CEA level after surgery had worst survival, and may be good candidates for adjuvant chemotherapy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638687     DOI: 10.1016/j.jss.2010.04.039

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  Declines in serum CYFRA21-1 and carcinoembryonic antigen as predictors of chemotherapy response and survival in patients with advanced non-small cell lung cancer.

Authors:  Liang Yang; Xin Chen; Yue Li; Jun Yang; Li Tang
Journal:  Exp Ther Med       Date:  2010-05-10       Impact factor: 2.447

2.  Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma.

Authors:  Zeng Wang; Shifeng Yang; Hongyang Lu
Journal:  Onco Targets Ther       Date:  2017-07-07       Impact factor: 4.147

3.  Postoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I pulmonary adenocarcinoma.

Authors:  Ying He; Yong Cui; Dong Chang; Tianyou Wang
Journal:  Oncotarget       Date:  2017-05-04

4.  Dual Immunomagnetic Nanobeads-Based Lateral Flow Test Strip for Simultaneous Quantitative Detection of Carcinoembryonic Antigen and Neuron Specific Enolase.

Authors:  Wenting Lu; Kan Wang; Kun Xiao; Weijian Qin; Yafei Hou; Hao Xu; Xinyu Yan; Yanrong Chen; Daxiang Cui; Jinghua He
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

5.  [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].

Authors:  Xinchun Duan; Yong Cui; Min Gong; Feng Tian; Guan Shi; Bingqun Wu; Mingliang Liu; Jiayun Guo; Yuanyuan Kong
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

Review 6.  [Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer].

Authors:  Bo Liu; Fengxia Ding; Shuangqiang Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

7.  Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.

Authors:  Yoshiki Kozu; Tomohiro Maniwa; Shoji Takahashi; Mitsuhiro Isaka; Yasuhisa Ohde; Takashi Nakajima
Journal:  J Cardiothorac Surg       Date:  2013-04-22       Impact factor: 1.637

8.  The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.

Authors:  Ai-Gui Jiang; Hong-Lin Chen; Hui-Yu Lu
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.